Cardiovascular Health in Lymphoma Survivors After Chemotherapy
We are studying how a type of chemotherapy called doxorubicin affects the heart and arteries. We are looking for lymphoma survivors and healthy adults to join this study.
Why this Research Matters
People who survive cancer may have changes in heart health after chemotherapy. In this study, we are working with lymphoma survivors who finished treatment to learn more about their heart health. What we learn will help future research and ways to support heart health in cancer survivors.
What to Expect
If you join, you’ll first take a short online survey to see if you qualify. Then, you’ll have a short meeting (in person or online) to learn about the study and sign a form. You’ll go to two visits at the Clinical Translational Research Center. There, you’ll do exams, give blood, fill out surveys, take a memory test, get body scans, and do tests to check your heart and blood vessels. You’ll also keep a food diary for a few days. You can choose to do an extra test to collect vein cells.
Study Duration
The study involves two in-person visits. During the first visit, which lasts about 2 hours, we will measure your blood pressure, collect information through lifestyle and health questionnaires, conduct memory tests, and perform body composition scans to assess muscle and fat. You’ll also be given a diet record to track everything you eat and drink for the next three days. The second visit takes about 3 hours and includes another blood pressure check, a blood draw, and vascular function tests. These tests use ultrasound and sensors to evaluate how your heart and blood vessels are working. This comprehensive approach helps us better understand cardiovascular health after chemotherapy.
Who can Participate
You may be able to join if:
- You are 18 or older
- You are a lymphoma survivor or a healthy adult
- If you had lymphoma, it’s been at least 4 weeks since your last doxorubicin chemotherapy
- You are not pregnant or breastfeeding
- You haven’t had hormone therapy in the past 12 months
- You haven’t taken MitoQ or CoQ10 supplements in the last month
Study ID
Protocol Number: 24-0908
More information available at ClinicalTrials.gov: NCT00000000
Compensation Information
Meet the Team
Principal Investigator